Eisenlohr-Moul TA

ORCID: 0000-0002-9231-3105 · 7 papers in corpus
other 2026
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology ·doi:10.1038/s41386-025-02267-0
other 2025
Psychoneuroendocrinology ·doi:10.1016/j.psyneuen.2025.107584

Despite decades of research, there is no scientific consensus method for representing the menstrual cycle as a continuous timeline. Common phase- and count-based methods oversimplify hormonal dynamics and overlook individual variability in …

other 2024
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology ·doi:10.1038/s41386-024-01931-1
other 2024
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology ·doi:10.1038/s41386-023-01687-0

The hormonal changes of pregnancy and parturition can trigger robust changes in affective state, particularly among patients with a history of postpartum depression. However, more work is needed to elucidate the temporal dynamics of symptom…

meta-analysis 2023
Frontiers in neuroendocrinology ·doi:10.1016/j.yfrne.2023.101098

UNLABELLED: Cyclic variations in hormones during the normal menstrual cycle underlie multiple central nervous system (CNS)-linked disorders, including premenstrual mood disorder (PMD), menstrual migraine (MM), and catamenial epilepsy (CE). …

other 2023
Trials ·doi:10.1186/s13063-023-07166-7

BACKGROUND: The perimenopausal transition is accompanied by psychiatric symptoms in over 10% of women. Symptoms commonly include depressed mood and anhedonia and less commonly include psychosis. Psychiatric symptoms have been linked to the …

rct 2017
Depression and anxiety ·doi:10.1002/da.22673

BACKGROUND: Although traditionally dosed combined oral contraceptives (COCs) (21 days of active pills, 7 days of inactive pills) have not been demonstrated as superior to placebo for the treatment of premenstrual dysphoria (PMD), some rando…